Advisory Services Network, LLC Cerus Corp Transaction History

Advisory Services Network, LLC

  • $5.15 Billion
  • Q4 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$3.38 - $4.22 $4,667 - $5,827
1,381 New
1,381 $5,000
Q2 2019

Aug 01, 2019
SELL
$4.51 - $6.6 $69,959 - $102,379
-15,512 Closed
0 $0
Q1 2019

May 20, 2019
SELL
$5.16 - $6.85 $2,523 - $3,349
-489 Reduced 3.06%
15,512 $97,000
Q4 2018

Feb 15, 2019
SELL
$4.89 - $7.16 $2,445 - $3,580
-500 Reduced 3.03%
16,001 $81,000
Q3 2018

Nov 02, 2018
SELL
$6.89 - $7.78 $3,644 - $4,115
-529 Reduced 3.11%
16,501 $119,000
Q2 2018

Jul 27, 2018
BUY
$5.19 - $7.25 $88,385 - $123,467
17,030 New
17,030 $130,000

Others Institutions Holding CERS

# of Institutions
160
Shares Held
144M
Call Options Held
22.5K
Put Options Held
23.6K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $328M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email